trial · primary record
CHM-029
AML (Acute Myeloid Leukemia)
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2029-03 |
| Primary endpoint | Number of participants with dose limiting toxicities (DLTs) |
| Registry ID | NCT07751991 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:28:34.014Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07751991
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.